Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conference
01 June 2022 - 12:42AM
Biofrontera
Inc. (Nasdaq: BFRI),
a biopharmaceutical company specializing in the commercialization
of dermatological products, announced today that the Company will
be participating in The Benchmark Healthcare House Call Virtual 1x1
Conference being held on June 2, 2022.
Erica Monaco, Chief Executive Officer and
Hermann Lübbert, Executive Chairman of Biofrontera Inc. will be
meeting with registered investors in virtual one-on-one meetings
and small-group sessions.
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based
biopharmaceutical company commercializing a portfolio of
pharmaceutical products for the treatment of dermatological
conditions with a focus on PDT and topical antibiotics. The
Company’s licensed products are used for the treatment of actinic
keratoses, which are pre-cancerous skin lesions, as well as
impetigo, a bacterial skin infection. For more information, visit
https://www.biofrontera-us.com.
Contacts
Biofrontera Inc.Anke zur
Mühlen+1 781 486 1539us-ir@biofrontera.com
LHA Investor RelationsTirth T.
Patel+1 212 201 6614tpatel@lhai.com
# # #
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Aug 2024 to Sep 2024
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Sep 2023 to Sep 2024